Xenogeneic human umbilical cord-derived mesenchymal stem cells reduce mortality in rats with acute respiratory distress syndrome complicated by sepsis

This study tested the hypothesis that xenogeneic human umbilical cord-derived mesenchymal stem cell (HUCDMSC) therapy would improve survival rates in rats with acute respiratory distress-syndrome (ARDS, induction by 48 h inhalation of 100% oxygen) and sepsis-syndrome (SS, induction by cecal-ligation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Fan-Yen, Chen, Kuan-Hung, Wallace, Christopher Glenn, Sung, Pei-Hsun, Sheu, Jiunn-Jye, Chung, Sheng-Ying, Chen, Yung-Lung, Lu, Hung-I, Ko, Sheung-Fat, Sun, Cheuk-Kwan, Chiang, Hsin-Ju, Chang, Hsueh-Wen, Lee, Mel S., Yip, Hon-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542214/
https://www.ncbi.nlm.nih.gov/pubmed/28484089
http://dx.doi.org/10.18632/oncotarget.17320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542214/
https://www.ncbi.nlm.nih.gov/pubmed/28484089
http://dx.doi.org/10.18632/oncotarget.17320

Ejemplares similares